Episode
A Positive (yet nuanced) MDMA Story
- Podcast
- Furthure
- Published
- Nov 22, 2024
- Duration seconds
- 4782
- Processing state
not_requested- Canonical source
- https://rss.com/podcasts/furthure/1767063
Actions
POST https://stenobird.com/v1/public/podcasts/furthure-6969644/episodes/a-positive-yet-nuanced-mdma-story/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/furthure-6969644/a-positive-yet-nuanced-mdma-story.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
MDMA-assisted psychotherapy did not get approved by the FDA. This shocked many, and the critiques surrounding the trial varied substantially in their constructiveness. Still, it is essential to remember that there are real people out there who benefited from their participation in the trial. So, I decided to let Becca Kacanda, a MAPS MDMA-assisted psychotherapy trial participant, tell us about her experience in the study, the good and the bad, and what she hopes future MDMA therapists, critics, and journalists can learn from the trial. If you enjoy the show, please subscribe! Follow Furthure @furthure707 on instagram and X. Bluesky: [email protected] X: @becca_kacanda NOTE: Becca stated she phased out of the trial two years ago in the audio, but it was actually three years ago.